Source: Annual Congress 2009 - Clinical immunology of tuberculosis
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
M. L. Olleros, D. Vesin, A. F. Lambou, J. P. Janssens, B. Ryffel, V. F. Quesniaux, D. E. Szymkowski, I. Garcia (Geneva, Switzerland; Orleans, France; Monrovia, United States Of America). A novel TNF inhibitor does not compromise host immunity to mycobacterium tuberculosis and BCG infections and still protects from hepatitis. Eur Respir J 2009; 34: Suppl. 53, 2564

Member's Comments

No comment yet.

Related content which might interest you: IgG-mediated humoral immune response against different mycobacterial antigens in tuberculosis (TB) and mycobacterial infections other than tuberculosis (MOTT) Source: Eur Respir J 2001; 18: Suppl. 33, 307s Year: 2001 Mucosal immunity and novel vaccines against tuberculosis Source: Lung Science Conference 2015 Year: 2015 Early BCG vaccination is unrelated to pulmonary immunity against Mycobacterium tuberculosis in adults Source: Eur Respir J 2014; 44: 1087-1090 Year: 2014 In vitro immune response to Mycobacterium tuberculosis antigens Source: Eur Respir J 2005; 26: Suppl. 49, 22s Year: 2005 Mycobacterium tilburgii infection in an HIV-seropositive host Source: Annual Congress 2009 - Tuberculosis and HIV co-infection Year: 2009 Mycobacterium tuberculosis bacteremia in reactivation tuberculosis patients without human immunodeficiency virus infection Source: Eur Respir J 2005; 26: Suppl. 49, 690s Year: 2005 Evaluating the use of the interferon-γ response to mycobacterium tuberculosis (MTB) specific antigens to diagnose latent tuberculosis infection in patients with chronic inflammatory joint and skin diseases Source: Annual Congress 2011 - Tuberculin skin tests, interferon-gamma release assays and beyond Year: 2011 Does BCG revaccination lead to enhanced protective immunity against tuberculosis? A study using surrogate markers Source: Annual Congress 2005 - Epidemiology and control of tuberculosis and LTBI Year: 2005 Impaired host defense against Mycobacterium avium in mice with chronic granulomatous disease Source: Annual Congress 2008 - New tests and methods to diagnose tuberculosis infection and disease and to monitor treatment Year: 2008 Interferon-? release assays for the diagnosis of latent Mycobacterium tuberculosis infection Source: Eur Respir J 2011; 38: 1238-1239 Year: 2011 Design of immunogenic multiepitopic mycobacterium tuberculosis peptides from genes selected using in vitro models of mycobacterial macrophage infection Source: Eur Respir J 2007; 30: Suppl. 51, 493s Year: 2007 Humoral immune response against 38-kDa and 16-kDa mycobacterial antigens in tuberculosis Source: Eur Respir J 2007; 29: 143-148 Year: 2007 HIV-1 infection impairs the bronchoalveolar immune response to mycobacteria Source: Annual Congress 2009 - Tuberculosis and HIV co-infection Year: 2009 Non-tuberculous mycobacteria: preventing infection and reinfection Source: International Congress 2019 – Respiratory infections: prevention is better than cure Year: 2019 Interferon-gamma release assays for the diagnosis of latent Mycobacterium tuberculosis infection Source: Eur Respir J 2011; 38: 1237-1238 Year: 2011 Therapeutic effect of adenoviral vector-mediated GM-CSF gene transfer in lung antimycobacterial immunity in M. bovis BCG infected mice Source: International Congress 2016 – Rifampicin resistance, MDRTB, and new drug treatments Year: 2016 The risk of latent Mycobacterium tuberculosis infection in HIV seropositive children not BCG vaccinated Source: Eur Respir J 2005; 26: Suppl. 49, 424s Year: 2005 Discriminating active from latent tuberculosis by Mycobacterium tuberculosis (MTB)-peptide specific immunoresponses Source: Annual Congress 2008 - Priorities for tuberculosis research in Europe: discussing the results of the Tuberculosis Network European Trials Group (TBNET) Year: 2008 Utility of mycobacterium tuberculosis Rv0081-specific host gene expression to distinguish latent infection from active tuberculosis disease Source: International Congress 2016 – Active and latent tuberculosis: biomarkers Year: 2016 Response to Rv2628 latency antigen associates with cured tuberculosis and remote infection Source: Eur Respir J 2010; 36: 135-142 Year: 2010